Loss of CD20 Expression and Exhaustion of Effector Cells Limit ADCC in CLL Patients Treated with Rituximab.

被引：1
|
作者：
Vire, Berengere [1 ]
Perry, Justin S. A. [2 ]
Lee, Elinor [1 ]
Stennett, Lawrence S. [1 ]
Samsel, Leigh [3 ]
McCoy, Philip [3 ]
Wilson, Wyndham H. [4 ]
Bielekova, Bibiana [2 ]
Wiestner, Adrian [1 ]
机构：
[1] NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA
[2] NINDS, Neuroimmunol Branch, NIH, Bethesda, MD 20892 USA
[3] NHLBI, Flow Cytometry Core Facil, NIH, Bethesda, MD 20892 USA
[4] NCI, CCR, NIH, Bethesda, MD 20892 USA
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
10.1182/blood.V114.22.1610.1610
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：643 / 644
页数：2
相关论文
共 50 条
  • [41] Role of CD20 expression and other pre-treatment risk factors in the development of infusion-related reactions in patients with CLL treated with obinutuzumab
    C L Freeman
    M Dixon
    R Houghton
    K-A Kreuzer
    G Fingerle-Rowson
    M Herling
    K Humphrey
    S Böttcher
    C S de Costa
    V Iglesias
    S Stilgenbauer
    J Gribben
    M Hallek
    V Goede
    Leukemia, 2016, 30 : 1763 - 1766
  • [42] Emergence of rituximab-fludarabine resistance is associated with changes in CD20 antigen expression-and improved response to almetuzumab therapy in patients with chronic lymphocytic leukemia (CLL)
    Ashraf, Umeer
    Elefante, Anjana N.
    Cruz, Raymond
    Wallace, Paul K.
    Czuczman, Myron S.
    Hernandez-Ilizaliturri, Franciscb J.
    BLOOD, 2007, 110 (11) : 612A - 612A
  • [43] Rituximab kills freshly isolated B-NHL and B-CLL more efficiently by complement than by ADCC in vitro. Role of CD20 expression levels and of the CD55 and CD59 complement inhibitors.
    Golay, J
    Facchinetti, V
    Gramigna, R
    Lazzari, M
    Dastoli, G
    Barbui, T
    Rambaldi, A
    Introna, M
    BLOOD, 2001, 98 (11) : 150A - 150A
  • [44] Modulation of CD20 Antigen Expression After Rituximab Treatment: A Retrospective Study in Patients With Chronic Lymphocytic Leukemia
    D'Auria, Fiorella
    Guariglia, Roberto
    Villani, Oreste
    Mansueto, Giovanna
    Grieco, Vitina
    Zonno, Antonia
    Bianchino, Gabriella
    Di Giovannantonio, Luigina
    Vita, Giulia
    Musto, Pellegrino
    CLINICAL THERAPEUTICS, 2010, 32 (11) : 1911 - 1916
  • [45] An anti-C3bi mAb enhances complement activation, C3bi deposition, and killing of CD20 positive cells by Rituximab.
    Taylor, RP
    Kennedy, AD
    Solga, MD
    Schuman, TA
    Chi, A
    Lindorfer, MA
    Sutherland, WM
    FASEB JOURNAL, 2002, 16 (04): : A664 - A664
  • [46] Loss of CD20 and Bound CD20 Antibody from Opsonized B Cells Occurs More Rapidly Because of Trogocytosis Mediated by Fc Receptor-Expressing Effector Cells Than Direct Internalization by the B Cells
    Beum, Paul V.
    Peek, Elizabeth M.
    Lindorfer, Margaret A.
    Beurskens, Frank J.
    Engelberts, Patrick J.
    Parren, Paul W. H. I.
    van de Winkel, Jan G. J.
    Taylor, Ronald P.
    JOURNAL OF IMMUNOLOGY, 2011, 187 (06): : 3438 - 3447
  • [47] The monitoring of CD20 expressing B-cells in peripheral blood of non-Hodgkins lymphoma (NHL) patients (pts) treated with rituximab (RTX).
    Lyass, O
    Barth, N
    Umiel, T
    Prilutskaya, M
    Bernhardt, B
    Moss, TJ
    BLOOD, 2001, 98 (11) : 230B - 230B
  • [48] Thrice-weekly low dose rituximab decreases CD20 loss via shaving and suggests enhanced therapeutic targeting in chronic lymphocytic leukemia (CLL)
    Taylor, R
    Williams, M
    Pawluczkowycz, A
    Beum, P
    Kennedy, A
    Lindorfer, M
    Barnd, D
    Patroni, G
    Eggleton, J
    Hamil, S
    Densmore, J
    ANNALS OF ONCOLOGY, 2005, 16 : 90 - 90
  • [49] NO EXPRESSION OF AN ALTERNATIVE CD20 TRANSCRIPT VARIANT IN B CELLS FROM PATIENTS WITH RHEUMATOID ARTHRITIS
    Deschamps, M.
    Gaugler, B.
    Saas, P.
    Ferrand, C.
    Toussirot, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 189 - 189
  • [50] No Expression of An Alternative CD20 Transcript Variant in B Cells From Patients with Rheumatoid Arthritis
    Deschamp, Marina
    Gaugler, Beatrice
    Saas, Philippe
    Ferrand, Christophe
    Toussirot, Eric
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S682 - S683
12345